For the first time in history, most people can expect to live into their 70s and 80s. But longer life has not meant healthier life. Around the world, the average person spends 9.6 years living with disease or disability, a figure that has grown 13% since 2000.
Precision medicine has transformed how we treat disease, matching therapies to the biology of each patient with a precision that was unimaginable a generation ago. But most of that progress arrives after someone is already sick. The next step is to bring the same rigor to the years before: predicting risk long before symptoms appear, preventing more disease than we treat, and ensuring that people receive precise treatment when they need it and the latest guidance and support throughout their lives, so care becomes continuous rather than episodic. All are essential to extending human healthspan.
In this session, Stanford Medicine shares the next chapter of its mission: a commitment to helping every person achieve their full healthspan. In conversation with leaders from Geneva University Hospitals and Apollo Hospitals, this panel will focus on the real and practical challenges of shifting care from reactive treatment to proactive intervention.